Cantor Fitzgerald Income Trust, Inc. filed a Form 8-K on November 6, 2026, disclosing that its board of directors declared October 2026 distributions across all classes of common stock and operating partnership units, with payment on or about November 6, 2026.
GeoVax Labs, Inc. filed an 8-K on November 6, 2026, disclosing that its Board of Directors terminated President and Chief Executive Officer David A. Dodd for Cause, effective November 5, 2026.
Fractyl Health, Inc. filed a Form 8-K on November 6, 2026, disclosing the appointment of Michael Wartell as an independent Class III director effective November 2, 2026, along with the terms of his compensation agreement.
Jaguar Health, Inc. filed an 8-K on November 6, 2026, disclosing the voting results from a special meeting of stockholders held that same day, at which all six submitted proposals were approved.
D. Boral Acquisition I Corp. filed a Form 8-K on November 6, 2026, disclosing the September 23, 2026 resignation of director Benjamin Piggott and subsequent board committee appointments.
Curis, Inc. filed a Form 8-K on November 6, 2026, disclosing that it received a Delist Determination Letter from Nasdaq on November 2, 2026, citing the company's failure to maintain the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq …
Nexentis Technologies Inc. filed a Form 8-K on November 6, 2026, disclosing that a 1-for-5 reverse stock split of its common stock became effective at 4:15 p.m. Eastern Time on November 6, 2026, with split-adjusted trading on The Nasdaq Capital Market set to begin …
Victory Capital Holdings, Inc. filed a DEFA14A and concurrent Form 8-K on November 6, 2026, providing supplemental disclosures to its definitive proxy statement in response to two stockholder lawsuits and demand letters related to the company's planned acquisition of First Eagle.
reAlpha Tech Corp. filed an 8-K on November 6, 2026, reporting the final voting results from its 2026 annual meeting of stockholders held on November 5, 2026, at which six proposals were submitted to a vote.
Hyatt Hotels Corporation filed a Form 8-K on November 6, 2026, disclosing under Regulation FD the number of restricted shares available for public sale by Pritzker family stockholders and other parties during the 12-month period beginning November 5, 2026.